brand logo

Am Fam Physician. 2021;104(2):206-207

Clinical Question

Are adult survivors of COVID-19 still experiencing significant symptoms four months or more after hospital discharge?

Bottom Line

This study found that more than one-half of the adults (51%) who had been hospitalized for COVID-19 reported a significant amount of persistent symptoms four months after discharge. (Level of Evidence = 1b)

Synopsis

The investigators identified a cohort of adult patients, 18 years or older, who had been admitted to a hospital in France for COVID-19 from March 1, 2020, to May 29, 2020. Inclusion criteria were survival at four months after hospital discharge and a diagnosis of SARS-CoV-2 infection by polymerase chain reaction or clinical features associated with typical findings on computed tomography (CT) of the lung. Of the 834 eligible patients, 478 (57%) consented to respond by telephone to a questionnaire about their general condition and respiratory, cognitive, and neurologic symptoms. All patients who had been admitted to the intensive care unit (ICU) and those with continued symptoms were invited for an in-person evaluation. All patients seen in person received high-resolution CT of the lungs and psychometric testing, including an interview with a neuropsychologist. All those admitted to the ICU underwent transthoracic echocardiography. More than one-half (51%) of the patients reported at least one symptom that did not exist before their COVID-19 infection, including fatigue (31.1%), memory difficulties (17.5%), dyspnea (16.3%), and persistent paresthesia (12.1%). Psychometric testing and evaluation confirmed cognitive impairment in 38.4% of patients. Persistent abnormalities on CT and echocardiography were also commonly noted, especially among patients who required admission to the ICU.

Study design: Cohort (prospective)

Funding source: Government

Setting: Inpatient (any location) with outpatient follow-up

Reference:Writing Committee for the COMEBAC Study GroupMorinLSavaleLPhamTet alFour-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA2021;325(15):1525–1534.

Already a member/subscriber?  Log In

Subscribe

From $145
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available

Article Only

$25.95
  • Immediate, unlimited access to just this article
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Sumi Sexton, MD, editor-in-chief.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.

Continue Reading

More in AFP

More in Pubmed

Copyright © 2021 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.